Home 2023

Systemic lupus erythematosus

AI-Based Drug Discovery Company Atomwise Sets Its Sights on Inflammatory Disease Market
Artificial Intelligence

AI-Based Drug Discovery Company Atomwise Sets Its Sights on Inflammatory Disease Market

Uduak Thomas -
0
Antibody Shows Promise against Autoimmune Diseases
Drug Discovery

Antibody Shows Promise against Autoimmune Diseases

Christina Jackson -
0
Two-Photon Microscopy Uncovers Role for Macrophages in Autoimmunity
News

Two-Photon Microscopy Uncovers Role for Macrophages in Autoimmunity

Julianna LeMieux, PhD -
0
Potential Approach for Treating Lupus Found
Genome Editing

Potential Approach for Treating Lupus Found

Christina Jackson -
0
Takeda Acquires Autoimmune Candidate from Nimbus for Up to $6B
Drug Discovery

Takeda Acquires Autoimmune Candidate from Nimbus for Up to $6B

Alex Philippidis -
0
Building Better Bispecifics
Bioprocessing

Building Better Bispecifics

John Sterling -
0
Pathway That Drives Inflammation in Autoimmune Diseases Uncovered
News

Pathway That Drives Inflammation in Autoimmune Diseases Uncovered

Christina Jackson -
0
Vaccine Booster Reduces Likelihood of Lupus Patients Having Breakthrough COVID Infection
Coronavirus

Vaccine Booster Reduces Likelihood of Lupus Patients Having Breakthrough COVID Infection

John Sterling -
0
Lupus Causing Mutation Identified in Humans
News

Lupus Causing Mutation Identified in Humans

Anjali A. Sarkar, PhD -
0
Leveraging Multiomics Data to Study Autoimmune Disease in the Era of Precision Medicine
Keynote

Leveraging Multiomics Data to Study Autoimmune Disease in the Era of Precision Medicine

Kathy Vuksanaj -
0
123...6Page 1 of 6
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.